ES2726573T3 - Proceso para la fabricación de 1-[2-(2,4-dimetil-fenilsulfanil)-fenil]-piperazina - Google Patents

Proceso para la fabricación de 1-[2-(2,4-dimetil-fenilsulfanil)-fenil]-piperazina Download PDF

Info

Publication number: ES2726573T3
Authority: ES; Spain
Prior art keywords: process according; compound; bis; mol; palladium
Prior art date: 2012-01-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

ES12815676T

Other languages

English (en)

Spanish (es)

Inventor

Kim Lasse Christensen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

H Lundbeck AS

Original Assignee

H Lundbeck AS

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-01-03

Filing date

2012-12-20

Publication date

2019-10-07

2012-12-20 Application filed by H Lundbeck AS filed Critical H Lundbeck AS

2012-12-20 Priority claimed from PCT/EP2012/076377 external-priority patent/WO2013102573A1/en

2019-10-07 Application granted granted Critical

2019-10-07 Publication of ES2726573T3 publication Critical patent/ES2726573T3/es

Status Active legal-status Critical Current

2032-12-20 Anticipated expiration legal-status Critical

Links

238000000034 method Methods 0.000 title claims abstract description 52
230000008569 process Effects 0.000 title claims abstract description 46
238000004519 manufacturing process Methods 0.000 title claims abstract description 17
YQNWZWMKLDQSAC-UHFFFAOYSA-N vortioxetine Chemical compound CC1=CC(C)=CC=C1SC1=CC=CC=C1N1CCNCC1 YQNWZWMKLDQSAC-UHFFFAOYSA-N 0.000 title description 7
150000001875 compounds Chemical class 0.000 claims abstract description 62
KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims abstract description 61
XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims abstract description 28
229910052763 palladium Inorganic materials 0.000 claims abstract description 26
150000003839 salts Chemical class 0.000 claims abstract description 19
125000006239 protecting group Chemical group 0.000 claims abstract description 16
239000003446 ligand Substances 0.000 claims abstract description 15
239000002904 solvent Substances 0.000 claims abstract description 15
229910000073 phosphorus hydride Inorganic materials 0.000 claims abstract description 14
239000003054 catalyst Substances 0.000 claims abstract description 13
239000001257 hydrogen Substances 0.000 claims abstract description 8
229910052739 hydrogen Inorganic materials 0.000 claims abstract description 8
LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims abstract description 6
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 4
125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 4
229910021645 metal ion Inorganic materials 0.000 claims abstract description 3
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Natural products CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 79
GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 46
239000000203 mixture Substances 0.000 claims description 25
UKSZBOKPHAQOMP-UHFFFAOYSA-N 1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].C=1C=CC=CC=1C=CC(=O)C=CC1=CC=CC=C1.C=1C=CC=CC=1C=CC(=O)C=CC1=CC=CC=C1 UKSZBOKPHAQOMP-UHFFFAOYSA-N 0.000 claims description 14
239000002253 acid Substances 0.000 claims description 13
BUNKQJAMHYKQIM-UHFFFAOYSA-N 1-iodo-2,4-dimethylbenzene Chemical compound CC1=CC=C(I)C(C)=C1 BUNKQJAMHYKQIM-UHFFFAOYSA-N 0.000 claims description 8
YUQUNWNSQDULTI-UHFFFAOYSA-N 2-bromobenzenethiol Chemical compound SC1=CC=CC=C1Br YUQUNWNSQDULTI-UHFFFAOYSA-N 0.000 claims description 8
KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 claims description 5
RYXZOQOZERSHHQ-UHFFFAOYSA-N [2-(2-diphenylphosphanylphenoxy)phenyl]-diphenylphosphane Chemical compound C=1C=CC=C(P(C=2C=CC=CC=2)C=2C=CC=CC=2)C=1OC1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RYXZOQOZERSHHQ-UHFFFAOYSA-N 0.000 claims description 5
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 5
ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims description 4
125000000217 alkyl group Chemical group 0.000 claims description 2
125000003118 aryl group Chemical group 0.000 claims description 2
125000006269 biphenyl-2-yl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C1=C(*)C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
LCSNDSFWVKMJCT-UHFFFAOYSA-N dicyclohexyl-(2-phenylphenyl)phosphane Chemical compound C1CCCCC1P(C=1C(=CC=CC=1)C=1C=CC=CC=1)C1CCCCC1 LCSNDSFWVKMJCT-UHFFFAOYSA-N 0.000 claims description 2
LUNZAASWPICGPB-UHFFFAOYSA-N dicyclohexyl-[2-(2,4,6-tripropylphenyl)phenyl]phosphane Chemical compound CCCC1=CC(CCC)=CC(CCC)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 LUNZAASWPICGPB-UHFFFAOYSA-N 0.000 claims description 2
125000003944 tolyl group Chemical group 0.000 claims description 2
IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 claims description 2
CYPYTURSJDMMMP-WVCUSYJESA-N (1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 claims 1
ZEMZPXWZVTUONV-UHFFFAOYSA-N 2-(2-dicyclohexylphosphanylphenyl)-n,n-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 ZEMZPXWZVTUONV-UHFFFAOYSA-N 0.000 claims 1
239000000010 aprotic solvent Substances 0.000 claims 1
MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical group C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 claims 1
239000012973 diazabicyclooctane Substances 0.000 claims 1
239000012535 impurity Substances 0.000 description 25
230000015572 biosynthetic process Effects 0.000 description 18
239000011541 reaction mixture Substances 0.000 description 18
238000006243 chemical reaction Methods 0.000 description 14
-1 thiol compounds Chemical class 0.000 description 11
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
239000002585 base Substances 0.000 description 9
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 8
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 8
238000001914 filtration Methods 0.000 description 8
VNGRUFUIHGGOOM-UHFFFAOYSA-N vortioxetine hydrobromide Chemical compound Br.CC1=CC(C)=CC=C1SC1=CC=CC=C1N1CCNCC1 VNGRUFUIHGGOOM-UHFFFAOYSA-N 0.000 description 8
238000000746 purification Methods 0.000 description 7
238000012369 In process control Methods 0.000 description 6
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
239000012458 free base Substances 0.000 description 6
238000004128 high performance liquid chromatography Methods 0.000 description 6
238000010965 in-process control Methods 0.000 description 6
GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 4
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
150000001412 amines Chemical class 0.000 description 4
239000013078 crystal Substances 0.000 description 4
239000012065 filter cake Substances 0.000 description 4
208000024714 major depressive disease Diseases 0.000 description 4
229910052757 nitrogen Inorganic materials 0.000 description 4
239000012299 nitrogen atmosphere Substances 0.000 description 4
150000007944 thiolates Chemical class 0.000 description 4
238000000825 ultraviolet detection Methods 0.000 description 4
FTYXWHNWGGQBIC-UHFFFAOYSA-N 1-[2-(2,4-dimethylphenyl)sulfanylphenyl]-4-(2-piperazin-1-ylphenyl)piperazine Chemical compound CC1=CC(C)=CC=C1SC1=CC=CC=C1N1CCN(C=2C(=CC=CC=2)N2CCNCC2)CC1 FTYXWHNWGGQBIC-UHFFFAOYSA-N 0.000 description 3
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
239000011260 aqueous acid Substances 0.000 description 3
125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 3
239000011261 inert gas Substances 0.000 description 3
125000004193 piperazinyl group Chemical group 0.000 description 3
239000000047 product Substances 0.000 description 3
150000003335 secondary amines Chemical class 0.000 description 3
239000011734 sodium Substances 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
NVRRNKGZNKULNX-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)-4-[2-(2,4-dimethylphenyl)sulfanylphenyl]piperazine Chemical compound CC1=CC(C)=CC=C1SC1=CC=CC=C1N1CCN(C=2C(=CC(C)=CC=2)C)CC1 NVRRNKGZNKULNX-UHFFFAOYSA-N 0.000 description 2
238000005160 1H NMR spectroscopy Methods 0.000 description 2
AMNLXDDJGGTIPL-UHFFFAOYSA-N 2,4-dimethylbenzenethiol Chemical compound CC1=CC=C(S)C(C)=C1 AMNLXDDJGGTIPL-UHFFFAOYSA-N 0.000 description 2
NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
238000005481 NMR spectroscopy Methods 0.000 description 2
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
230000008901 benefit Effects 0.000 description 2
ZDZHCHYQNPQSGG-UHFFFAOYSA-N binaphthyl group Chemical group C1(=CC=CC2=CC=CC=C12)C1=CC=CC2=CC=CC=C12 ZDZHCHYQNPQSGG-UHFFFAOYSA-N 0.000 description 2
238000010511 deprotection reaction Methods 0.000 description 2
VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
229910052736 halogen Inorganic materials 0.000 description 2
150000002367 halogens Chemical class 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
229960005235 piperonyl butoxide Drugs 0.000 description 2
229940068196 placebo Drugs 0.000 description 2
239000000902 placebo Substances 0.000 description 2
QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
238000007086 side reaction Methods 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
150000003573 thiols Chemical class 0.000 description 2
SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
XUKUURHRXDUEBC-SXOMAYOGSA-N (3s,5r)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-SXOMAYOGSA-N 0.000 description 1
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
RUIMBVCRNZHCRQ-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)piperazine Chemical compound CC1=CC(C)=CC=C1N1CCNCC1 RUIMBVCRNZHCRQ-UHFFFAOYSA-N 0.000 description 1
JVTRURBMYILQDA-UHFFFAOYSA-N 1-(2-bromophenyl)piperazine Chemical compound BrC1=CC=CC=C1N1CCNCC1 JVTRURBMYILQDA-UHFFFAOYSA-N 0.000 description 1
OIRHKGBNGGSCGS-UHFFFAOYSA-N 1-bromo-2-iodobenzene Chemical compound BrC1=CC=CC=C1I OIRHKGBNGGSCGS-UHFFFAOYSA-N 0.000 description 1
AAEQXEDPVFIFDK-UHFFFAOYSA-N 3-(4-fluorobenzoyl)-2-(2-methylpropanoyl)-n,3-diphenyloxirane-2-carboxamide Chemical compound C=1C=CC=CC=1NC(=O)C1(C(=O)C(C)C)OC1(C=1C=CC=CC=1)C(=O)C1=CC=C(F)C=C1 AAEQXEDPVFIFDK-UHFFFAOYSA-N 0.000 description 1
206010002869 Anxiety symptoms Diseases 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
206010054089 Depressive symptom Diseases 0.000 description 1
SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
102000019208 Serotonin Plasma Membrane Transport Proteins Human genes 0.000 description 1
108010012996 Serotonin Plasma Membrane Transport Proteins Proteins 0.000 description 1
HHRFWSALGNYPHA-UHFFFAOYSA-N [N].C1CNCCN1 Chemical compound [N].C1CNCCN1 HHRFWSALGNYPHA-UHFFFAOYSA-N 0.000 description 1
CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Substances CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 1
OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
229960004373 acetylcholine Drugs 0.000 description 1
239000000556 agonist Substances 0.000 description 1
230000001476 alcoholic effect Effects 0.000 description 1
239000005557 antagonist Substances 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
238000009835 boiling Methods 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
244000309464 bull Species 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
230000003001 depressive effect Effects 0.000 description 1
238000001514 detection method Methods 0.000 description 1
229960003638 dopamine Drugs 0.000 description 1
230000000694 effects Effects 0.000 description 1
239000012467 final product Substances 0.000 description 1
230000036541 health Effects 0.000 description 1
229960001340 histamine Drugs 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
238000002955 isolation Methods 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
239000012035 limiting reagent Substances 0.000 description 1
230000007774 longterm Effects 0.000 description 1
230000010534 mechanism of action Effects 0.000 description 1
239000002858 neurotransmitter agent Substances 0.000 description 1
229960002748 norepinephrine Drugs 0.000 description 1
SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
150000007530 organic bases Chemical class 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 1
YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
239000004031 partial agonist Substances 0.000 description 1
UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
YZTJYBJCZXZGCT-UHFFFAOYSA-N phenylpiperazine Chemical group C1CNCCN1C1=CC=CC=C1 YZTJYBJCZXZGCT-UHFFFAOYSA-N 0.000 description 1
150000004885 piperazines Chemical class 0.000 description 1
LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
230000001376 precipitating effect Effects 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
238000010926 purge Methods 0.000 description 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
239000000376 reactant Substances 0.000 description 1
238000010992 reflux Methods 0.000 description 1
229940076279 serotonin Drugs 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000012453 solvate Substances 0.000 description 1
241000894007 species Species 0.000 description 1
RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Substances SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 1
230000009466 transformation Effects 0.000 description 1
238000000844 transformation Methods 0.000 description 1
IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
238000004704 ultra performance liquid chromatography Methods 0.000 description 1
239000008096 xylene Substances 0.000 description 1

Landscapes

Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

ES12815676T 2012-01-03 2012-12-20 Proceso para la fabricación de 1-[2-(2,4-dimetil-fenilsulfanil)-fenil]-piperazina Active ES2726573T3 (es)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201261582527P	2012-01-03	2012-01-03
DKPA201200006		2012-01-03
PCT/EP2012/076377 WO2013102573A1 (en)	2012-01-03	2012-12-20	Process for the manufacture of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine

Publications (1)

Publication Number	Publication Date
ES2726573T3 true ES2726573T3 (es)	2019-10-07

Family

ID=67702058

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES12815676T Active ES2726573T3 (es)	2012-01-03	2012-12-20	Proceso para la fabricación de 1-[2-(2,4-dimetil-fenilsulfanil)-fenil]-piperazina

Country Status (5)

Country	Link
ES (1)	ES2726573T3 (de)
HU (1)	HUE043092T2 (de)
ME (1)	ME03428B (de)
PT (1)	PT2800746T (de)
TR (1)	TR201906892T4 (de)

2012
- 2012-12-20 TR TR2019/06892T patent/TR201906892T4/tr unknown
- 2012-12-20 HU HUE12815676A patent/HUE043092T2/hu unknown
- 2012-12-20 ME MEP-2019-120A patent/ME03428B/de unknown
- 2012-12-20 ES ES12815676T patent/ES2726573T3/es active Active
- 2012-12-20 PT PT12815676T patent/PT2800746T/pt unknown

Also Published As

Publication number	Publication date
HUE043092T2 (hu)	2019-08-28
PT2800746T (pt)	2019-05-31
ME03428B (de)	2020-01-20
TR201906892T4 (tr)	2019-06-21

Publication	Publication Date	Title
RU2608307C2 (ru)	2017-01-17	Способ получения 1-[2-(2,4-диметилфенилсульфанил)фенил]пиперазина
ES2774178T3 (es)	2020-07-17	Síntesis de derivados de 1h-pirrolo[2,3-B] piridina que modulan cinasas
ES2561111T3 (es)	2016-02-24	Arilalquilaminas y procedimiento para la producción de las mismas
ES3024232T3 (en)	2025-06-04	Fenfluramine compositions and methods of preparing the same
ES2954474T3 (es)	2023-11-22	Sales de adición de ácido de succinato y fumarato de derivados de piperazina útiles como inhibidores de glucosidasa
ES2527046T3 (es)	2015-01-19	Método para la preparación de un compuesto de éster del ácido borónico
AU2023285937A1 (en)	2024-01-25	Compounds
KR20150118146A (ko)	2015-10-21	보르티옥세틴 제조 방법
PT99368A (pt)	1992-09-30	Processo para a preparacao de derivados de piperazina
ES2664418T3 (es)	2018-04-19	Compuestos de fluorofenil pirazol
WO2013112722A1 (en)	2013-08-01	Inhibitors of rho associated protein kinases (rock) and methods of use
CA3162470A1 (en)	2021-05-27	Caspase 6 inhibitors and uses thereof
ES2726573T3 (es)	2019-10-07	Proceso para la fabricación de 1-[2-(2,4-dimetil-fenilsulfanil)-fenil]-piperazina
ES2370986B1 (es)	2012-11-16	Nuevos inhibidores de cxcr4 como agentes anti-vih
ES2236971T3 (es)	2005-07-16	Derivados del indol utiles, entre otras cosas, para el tratamiento de la osteoporosis.
BR112018072869B1 (pt)	2024-02-27	Compostos de s-triazina 2,4,6-trissubstituídos, seus usos, e composição farmacêutica
ES2940184T3 (es)	2023-05-04	Derivados de 4-pirazin-2-ilmetil-morfolina y uso de los mismos como medicamento
ES2339816T3 (es)	2010-05-25	Moduladores de receptores nicotinicos alfa 7 de acetilcolina y usos terapeuticos de los mismos.
ES2967094T3 (es)	2024-04-26	Compuesto de pirrolidina ópticamente activo y procedimiento de producción del mismo
Zhao et al.	2018	Discovery and optimization of 2-thio-5-amino substituted benzoquinones as potent anticancer agents
HK1200827B (en)	2020-02-21	Process for the manufacture of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine
BR112021001963B1 (pt)	2024-02-15	Compostos de borato de um derivado de azetidina, composição farmacêutica que compreende os ditos compostos e uso dos mesmos para prevenção ou tratamento de mieloma múltiplo
ES2975743A1 (es)	2024-07-12	Metodo de preparacion de mitapivat, intermedios de sintesis de mitapivat y metodos de preparacion de los mismos
WO2024159287A1 (pt)	2024-08-08	Hidroxamatos bloqueadores de nav 1.7 e/ou nav 1.8, seus processos de obtenção, composições, usos, métodos de tratamento destes e kits
RU2605603C1 (ru)	2016-12-27	N,n'-бис(3-бромпропионил)-n,n'-диметил-1,2-этилендиамин, способ его получения и применение его в качестве водорастворимого реагента, проявляющего противоопухолевые свойства